Most of what is known comes from: So when someone searches for BPC 157 weight loss, it is important to set expectations right away: this is not comparable to clinically validated obesity therapies backed by decades of clinical outcome data, standardized dosing, and predictable effects on appetite and metabolic pathways, such as FDA-approved options like semaglutide (Wegovy) and tirzepatide (Zepbound)
Jaeschke H, Bajt ML
The September 2023 503A bulks-list update placed BPC-157 in Category 2, citing insufficient evidence for the FDA to determine that compounding it for routine clinical use is safe and effective
Adding GHK-Cu creates the GLOW stack - the most comprehensive tissue repair and skin/collagen protocol in clinical use
By improving hydration levels from within, B12 injections help your skin appear plumper and more refreshed
PMID: 16099219[PubMed Reference] Sosne G, Qiu P, Goldstein AL, Wheater M